CompletedNot Applicable

Organ/Space Surgical Site Infection and Recurrence and Survival in Rectal Cancer Surgery

Spain3,826 participantsStarted 2011-01-01

Plain-language summary

In rectal cancer surgery, the organ/space surgical site infection (O/S-SSI) has an impact on patient's prognosis. Its influence in the oncologic outcomes remains controversial. The main objective is to assess the possible effect of O/S-SSI on long-term overall survival and cancer recurrence.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients \> 18 years old * Eligible patients with tumour ≤ 13 cm from anal verge, as measured by Magnetic Resonance Imaging * Primary adenocarcinoma * Oncological resection with curative intent * Cancer stages: I-II-III Exclusion Criteria: * Transanal local resection * Emergency colorectal surgeries * Presence of metastases found in the diagnostic process or during the surgical procedure * Recurrence of the disease treated before the study period * Non-resectable tumour or palliative surgery * Patients operated in private centres

What they're measuring

Rate of overall cancer recurrence

Timeframe: 5 years (from date of the surgical procedure until 5 years post-surgery)

Overall survival

Timeframe: From date of the surgical procedure until the date of death, assessed up to 5 years

Trial details

NCT IDNCT06382415

SponsorHospital de Granollers

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-12-31

View on ClinicalTrials.gov More Rectal Cancer trials